Market closedNon-fractional
Zimmer Biomet/ZBH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Zimmer Biomet
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Ticker
ZBH
Sector
Healthcare
Trading on
NYSE
Industry
Health Care Equipment and Supplies
Headquarters
Warsaw, United States
Employees
18,000
Website
www.zimmerbiomet.com
Zimmer Biomet Metrics
BasicAdvanced
$23B
Market cap
23.97
P/E ratio
$4.62
EPS
1.02
Beta
$0.96
Dividend rate
0.87%
Dividend yield
Price and volume
Market cap
$23B
Beta
1.02
Dividend rate
$0.96
Financial strength
Current ratio
1.656
Quick ratio
0.658
Long term debt to equity
39.654
Total debt to equity
47.626
Dividend payout ratio (TTM)
20.75%
Interest coverage (TTM)
7.44%
Management effectiveness
Return on assets (TTM)
4.44%
Return on equity (TTM)
7.80%
Valuation
Price to earnings (TTM)
23.972
Price to revenue (TTM)
3.083
Price to book
1.8
Price to tangible book (TTM)
-24.72
Price to free cash flow (TTM)
28.483
Dividend yield (TTM)
0.87%
Growth
Revenue change (TTM)
4.85%
Earnings per share change (TTM)
115.66%
3-year revenue growth (CAGR)
2.89%
3-year earnings per share growth (CAGR)
19.15%
What the Analysts think about Zimmer Biomet
Analyst Ratings
Majority rating from 29 analysts.
Zimmer Biomet Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$1.9B
-2.62%
Net income
$172M
-58.87%
Profit margin
9.12%
-57.78%
Zimmer Biomet Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$1.82
$1.65
$2.20
$1.94
-
Expected
$1.81
$1.60
$2.15
$1.87
$1.99
Surprise
0.57%
3.28%
2.11%
3.78%
-
Zimmer Biomet News
AllArticlesVideos
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2024 Financial Results
PRNewsWire·3 weeks ago
Zimmer Biomet Holdings, Inc. (ZBH) Q1 2024 Earnings Call Transcript
Seeking Alpha·3 months ago
Zimmer Biomet beats Q1 profit estimates on robust demand for knee, hip devices
Reuters·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
Jul
31
Zimmer Biomet
Dividend·Payment
$0.24
Per share
FAQs
What’s the current market cap for Zimmer Biomet stock?
Zimmer Biomet (ZBH) has a market cap of $23B as of July 27, 2024.
What is the P/E ratio for Zimmer Biomet stock?
The price to earnings (P/E) ratio for Zimmer Biomet (ZBH) stock is 23.97 as of July 27, 2024.
Does Zimmer Biomet stock pay dividends?
Yes, the Zimmer Biomet (ZBH) stock pays dividends to shareholders. As of July 27, 2024, the dividend rate is $0.96 and the yield is 0.87%. Zimmer Biomet has a payout ratio of 20.75% on a trailing twelve-month basis.
When is the next Zimmer Biomet dividend payment date?
The next Zimmer Biomet (ZBH) dividend payment is scheduled for July 31, 2024.
What is the beta indicator for Zimmer Biomet?
Zimmer Biomet (ZBH) has a beta rating of 1.02. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Zimmer Biomet stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.